Differential Effects of Traumatic Brain Injury on the Cytochrome P450 System: A Perspective into Hepatic and Renal Drug Metabolism

Journal of Neurotrauma

Volumn 20, Issue 12, 2003, Pages 1339-1350

  Kalsotra, Auinash ^a   Turman, Cheri M ^a   Dash, Pramod K ^a   Strobel, Henry W ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

CYP450 drug substrates; Inflammation and injury; Leukotriene B4; Tissue specific response

Indexed keywords

ACETYLSALICYLIC ACID; AMFEBUTAMONE; BENZPHETAMINE; CHLORPROMAZINE; CHLORZOXAZONE; CLOZAPINE; CYTOCHROME P450; CYTOCHROME P450 1A; CYTOCHROME P450 2B; CYTOCHROME P450 2D; CYTOCHROME P450 3A; CYTOCHROME P450 4F; CYTOCHROME P450 ISOENZYME; CYTOCHROME P450 REDUCTASE; DIAZEPAM; HALOPERIDOL; MIANSERIN; MIXED FUNCTION OXIDASE; NAPROXEN; PARACETAMOL; PHENACETIN; PHENYLBUTAZONE; PHENYTOIN; RILUZOLE; TACRINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL; WARFARIN; ZOTEPINE; ZOXAZOLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DRUG CLEARANCE; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME SUBSTRATE COMPLEX; IMMUNOBLOTTING; KIDNEY METABOLISM; LIVER METABOLISM; MALE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT;

EID: 0345731378     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/089771503322686139     Document Type: Article

References (55)

1. ABDEL-RAZZAK, Z., CORCOS, L., FAUTREL, A., et al. (1995). Interleukin-1 beta antagonizes phenobarbital induction of several major cytochromes P450 in adult rat hepatocytes in primary culture. FEBS Lett. 366, 159-164.
2. ABDEL-RAZZAK, Z., LOYER, P., FAUTREL, A., et al. (1993). Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol. Pharmacol. 44, 707-715.
3. ANZENBACHER, P., and ANZENBACHEROVA, E. (2001). Cytochromes P450 and metabolism of xenobiotics. Cell. Mol. Life Sci. 58, 737-747.
4. BARKER, C., FAGAN, J., and PASCO, D. (1992). Interleukin-1 beta suppresses the induction of P4501A1 and P4501A2 mRNAs in isolated hepatocytes. J. Biol. Chem. 267, 8050-8055.
5. BOUCHER, B.A., KUHL, D.A., FABIAN, T.C., et al. (1991). Effect of neurotrauma on hepatic drug clearance. Clin. Pharmacol. Ther. 50, 487-497.
6. CHEN, J.Q., STROM, A., GUSTAFSSON, J.A., et al. (1995). Suppression of the constitutive expression of cytochrome P-450 2C11 by cytokines and interferons in primary cultures of rat hepatocytes: comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in the suppressive response to interleukins 1 and 6. Mol. Pharmacol. 47, 940-947.
7. CHEN, Z.L., INDYK, J.A., BUGGE, T.H., et al. (1999). Neuronal death and blood-brain barrier breakdown after excitotoxic injury are independent processes. J. Neurosci. 19, 9813-9820.
8. CLARK, M.A., WILLIAMS, J.F., GOTTSCHALL, P.E., et al. (1996). Effects of phenobarbital and interleukin-6 on cytochrome P4502B1 and 2B2 in cultured rat hepatocytes. Biochem. Pharmacol. 51, 701-706.
9. CLIFTON, G.L., ROBERTSON, C.S., KYPER, K., et al. (1983). Cardiovascular response to severe head injury. J. Neurosurg. 59, 447-454.
10. CRESPI, C.L., MILLER, V.P., and PENMAN, B.W. (1997). Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. Anal. Biochem. 248, 188-190.
11. CUI, X., KALSOTRA, A., ROBIDA, A.M., et al. (2003). Expression of cytochromes P450 4F4 and 4F5 in infection and injury models of inflammation. Biochim. Biophys. Acta 1619, 325-331.
12. DASH, P.K., MACH, S.A., and MOORE, A.N. (2002). The role of extracellular signal-regulated kinase in cognitive and motor deficits following experimental traumatic brain injury. Neuroscience 114, 755-767.
13. DIGNAM, J.D., and STROBEL, H.W. (1977). NADPH-cytochrome P-450 reductase from rat liver: purification by affinity chromatography and characterization. Biochemistry 16, 1116-1123.
14. DIXON, C.E., CLIFTON, G.L., LIGHTHALL, J.W., et al. (1991). A controlled cortical impact model of traumatic brain injury in the rat. J Neurosci Methods 39, 253-262.
15. FISHER, A.J., DONNELLY, S.C., HIRANI, N., et al. (1999). Enhanced pulmonary inflammation in organ donors following fatal non-traumatic brain injury. Lancet 353, 1412-1413.
16. FORD-HUTCHINSON, A.W., BRAY, M.A., DOIG, M.V., et al. (1980). Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286, 264-265.
17. GENG, J., and STROBEL, H.W. (1998). Expression, induction and regulation of the cytochrome P450 monooxygenase system in the rat glioma C6 cell line. Brain Res 784, 276-283.
18. GUENGERICH, F.P. (1991). Reactions and significance of cytochrome P-450 enzymes. J. Biol. Chem. 266, 10019-10022.
19. GUENGERICH, F.P., and MASON, P.S. (1979). Immunological comparison of hepatic and extrahepatic cytochromes P450. Mol. Pharmacol. 15, 154-164.
20. HEINEMEYER, G., ROOTS, I., and DENNHARDT, R. (1986). Monitoring of pentobarbital plasma levels in critical care patients suffering from increased intracranial pressure. Ther. Drug Monit. 8, 145-150.
21. HIROI, T., IMAOKA, S., CHOW, T., et al. (1998). Tissue distributions of CYP2D1, 2D2, 2D3 and 2D4 mRNA in rats detected by RT-PCR. Biochim. Biophys. Acta 1380, 305-312.
22. KALSOTRA, A., ANAKK, S., BOEHME, C.L., et al. (2002). Sexual dimorphism and tissue specificity in the expression of CYP4F forms in Sprague-Dawley rats. Drug Metab. Dispos. 30, 1022-1028.
23. KAWASHIMA, H., KUSUNOSE, E., THOMPSON, C.M., et al. (1997). Protein expression, characterization, and regulation of CYP4F4 and CYP4F5 cloned from rat brain. Arch. Biochem. Biophys. 347, 148-154.
24. KIKUTA, Y., KUSUNOSE, E., and KUSUNOSE, M. (2002). Prostaglandin and leukotriene omega-hydroxylases. Prostaglandins Other Lipid Mediat. 68-69, 345-362.
25. KRAUS, M.F. (1999). Neuropsychiatric sequelae: assessment and pharmacological Interventions, in: Traumatic Brain Injury. D.W. Marion (ed), Thieme Medical Publishers: New York, pps. 173-185.
26. LAEMMLI, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
27. LASKER, J.M., CHEN, W.B., WOLF, I., et al. (2000). Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11. J. Biol. Chem. 275, 4118-4126.
28. LU, A.Y., STROBEL, H.W., and COON, M.J. (1970). Properties of a solubilized form of the cytochrome P-450-containing mixed-function oxidase of liver microsomes. Mol. Pharmacol. 6, 213-220.
29. MARION, D.W. (1999). Management of traumatic brain injury: past, present, and future. Clin. Neurosurg. 45, 184-191.
30. MCINTOSH, T.K., JUHLEN, M., RAGHUPATHI, R., et al. (1999). Secondary brain injury: neurochemical and cellular mediators in traumatic brain injury, in: Traumatic Brain Injury. D.W. Marion (ed), Thieme Medical Publishers: New York, pps. 39-54.
31. MCKINDLEY, D.S., BOUCHER, B.A., HESS, M.M., et al. (1997). Effect of acute phase response on phenytoin metabolism in neurotrauma patients. J. Clin. Pharmacol. 37, 129-139.
32. McKINDLEY, D.S., HANES, S., and BOUCHER, B.A. (1998). Hepatic drug metabolism in critical illness. Pharmacotherapy 18, 759-778.
33. MORGAN, E.T. (1991). Suppression of P450IIC12 gene expression and elevation of actin messenger ribonucleic acid levels in the livers of female rats after injection of the interferon inducer poly rI.poly rC. Biochem. Pharmacol. 42, 51-57.
34. MORGAN, E.T. (1997). Regulation of cytochromes P450 during inflammation and infection. Drug Metab. Rev. 29, 1129-1188.
35. MORGAN, E.T., THOMAS, K.B., SWANSON, R., et al. (1994). Selective suppression of cytochrome P-450 gene expression by interleukins 1 and 6 in rat liver. Biochim. Biophys. Acta 1219, 475-483.
36. NEBERT, D.W., and GONZALEZ, F.J. (1987). P450 genes: structure, evolution, and regulation. Annu. Rev. Biochem. 56, 945-993.
37. NEBERT, D.W., and RUSSELL, D.W. (2002). Clinical importance of the cytochromes P450. Lancet 360, 1155-1162.
38. NELSON, D.R. (1999). Cytochrome P450 and the individuality of species. Arch. Biochem. Biophys. 369, 1-10.
39. O'MARA, N.B., JONES, P.R., ANGLIN, D.L., et al. (1995). Pharmacokinetics of phenytoin in children with acute neurotrauma. Crit. Care Med. 23, 1418-1424.
40. OMURA, T., and SATO, R. (1964). The carbon monoxide-binding pigment of liver microsomes. J. Biol. Chem. 239, 2370-2378.
41. OTT, L., MCCLAIN, C.J., GILLESPIE, M., et al. (1994). Cytokines and metabolic dysfunction after severe head injury. J. Neurotrauma 11, 447-472.
42. POLOYAC, S.M., PEREZ, A., SCHEFF, S., et al. (2001). Tissue-specific alterations in the 6-hydroxylation of chlorzoxazone following traumatic brain injury in the rat. Drug Metab. Dispos. 29, 296-298.
43. RENTON, K.W. (2001). Alteration of drug biotransformation and elimination during infection and inflammation. Pharmacol. Ther. 92, 147-163.
44. RENTON, K.W., and NICHOLSON, T.E. (2000). Hepatic and central nervous system cytochrome P450 are down-regulated during lipopolysaccharide-evoked localized inflammation in brain. J. Pharmacol. Exp. Ther. 294, 524-530.
45. SABEL, B.A., and STEIN, D.G. (1986). Pharmacological treatment of central nervous system injury. Nature 323, 493.
46. SCHOETTLE, R.J., KOCHANEK, P.M., MAGARGEE, M.J., et al. (1990). Early polymorphonuclear leukocyte accumulation correlates with the development of posttraumatic cerebral edema in rats. J. Neurotrauma 7, 207-217.
47. SHIMAMOTO, Y., KITAMURA, H., HOSHI, H., et al. (1998). Differential alterations in levels of hepatic microsomal cytochrome P450 isozymes following intracerebroventricular injection of bacterial lipopolysaccharide in rats. Arch. Toxicol. 72, 492-498.
48. STRESSER, D.M., TURNER, S.D., BLANCHARD, A.P., et al. (2002). Cytochrome P450 fluorometric substrates: identification of isoform-selective probes for rat CYP2D2 and human CYP3A4. Drug Metab. Dispos. 30, 845-852.
49. STROBEL, H.W., GENG, J., KAWASHIMA, H., et al. (1997). Cytochrome P450-dependent biotransformation of drugs and other xenobiotic substrates in neural tissue. Drug Metab. Rev. 29, 1079-1105.
50. STROBEL, H.W., HODGSON, A.V., and SHEN, S. (1995). NADPH cytochrome P450 reductase and its structural and functional domains, in: Cytochrome P450-Structure, Mechanism and Biochemistry. P.R. Oritz-De Montellano (ed), Plenum: New York, pps. 225-244.
51. TOLER, S.M., YOUNG, A.B., McCLAIN, C.J., et al. (1993). Head injury and cytochrome P-450 enzymes. Differential effect on mRNA and protein expression in the Fischer-344 rat. Drug Metab. Dispos. 21, 1064-1069.
52. WANG, H., and STROBEL, H.W. (1997). Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli. Arch. Biochem. Biophys. 344, 365-372.
53. WOICIECHOWSKY, C., ASADULLAH, K., NESTLER, D., et al. (1998). Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat. Med. 4, 808-813.
54. WOICIECHOWSKY, C., SCHONING, B., COBANOV, J., et al. (2002). Early IL-6 plasma concentrations correlate with severity of brain injury and pneumonia in brain-injured patients. J. Trauma 52, 339-345.
55. XU, J.A., HSU, C.Y., LIU, T.H., et al. (1990). Leukotriene B4 release and polymorphonuclear cell infiltration in spinal cord injury. J. Neurochem. 55, 907-912.